期刊文献+

系统性硬化症肺部高分辨率CT影像学表现分析 被引量:3

Imaging manifestations of high resolution CT in patients with systemic sclerosis
下载PDF
导出
摘要 目的探讨系统性硬化症(SSc)肺部高分辨率CT(HRCT)影像学特征。方法回顾性分析2013-02~2017-04该院临床确诊15例SSc肺部HRCT影像学表现。结果 15例SSc患者肺部正常4例,表现以两肺外围分布为主的间质性纤维化11例。HRCT主要表现支气管血管束扭曲变形、小叶间隔增厚,可见条索状影、胸膜下线及弧形线9例,呈网格状改变7例。沿支气管血管束及小叶间隔分布小结节状影,胸膜下见小结节影10例。单纯以磨玻璃样改变5例,轻度胸膜增厚或少量胸腔积液9例。小片状实变影及蜂窝肺4例。结论 HRCT显示SSc的间质性细微病变,在SSc的诊断和随访治疗中具有重要价值。 Objective To study the imaging manifestations of high resolution CT( HRCT) in patients with systemic sclerosis( SSc). Methods The imaging manifestations of HRCT in 15 patients with clinically diagnosed SSc were analyzed retrospectively. Results The lungs were normal in 4 cases and had interstitial fibrosis with peripheral distribution in 11 cases. HRCT was mainly manifested in distortions of the bronchovascular bundles and the thickening of the interlobular septum,strips,inferior pleural lines and the curved lines in 9 cases,and in a grid change in 7 cases. Small nodules were distributed along the bronchial vascular bundles and lobular septum,and small nodules under the pleura in 10 cases. Simple grinding glass change was found in 5 cases. Mild pleural thickening or a small amount of pleural effusion was found in 9 cases. Small flaky solid and honeycomb lungs were found in 4 cases. Conclusion HRCT shows the minute structure changes of interstitial lung disease in SSc,which is of great value in the diagnosis and follow-up treatment for SSc.
作者 韦红星 麻淑环 冯秋花 WEI Hong-xing;MA Shu-huan;FENG Qiu-hua(Department of Radiology,the People's Hospital of Tiandeng County,Guangxi 532800,Chin)
出处 《中国临床新医学》 2018年第5期487-489,共3页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
关键词 系统性硬化症 间质性肺疾病 体层摄影术 X线计算机 Systemic sclerosis Interstitial lung disease Tomography X-ray computer
  • 相关文献

参考文献2

二级参考文献31

  • 1特发性肺纤维化诊断及治疗(试行方案)[J].中华结核和呼吸杂志,1994,17(1):8-8. 被引量:103
  • 2Winstone TA,Assayag D, Wilcox PG, et al. Predictors of mortality and progression in seleroderma associated interstitial lung disease: a systematic review [J]. Chest, 2014,146(2) :422 - 436.
  • 3KajiiM, Suzuki C, Kashihara J, et al. Prevention of excessive collagen accumulation by human intravenous immunoglobulin treatment in a murine model of bleomycin-induced seleroderma[J]. Clin Exp Immunol , 2011,163(2) :235 - 241.
  • 4Zhang L,Fu XH,Yu Y,etal. Treatment with CA-074Me, Cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model of polymyositis [J]. Lab Invest,2015,95(1) :65 - 77.
  • 5Yamamoto T, Takagawa S, Katayama I, et al. Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking Scleroderma[J]. J Invest Dermatol, 1999,112 (4) : 456 - 462.
  • 6Oi M,Yamamoto T, Nishioka K. Increased expression of TGF-betal in the sclerotic skin in bleomycin susceptible' mouse strains[J]. J Med Dent Sci, 2004,51 (1) : 7 - 17.
  • 7Burger RM. Cleavage of Nucleic Acids by Bleomycin[J]. ChemRev,1998,98(3) :1153- 1170.
  • 8Bhattaeharyya S, Wei J, Varga J. Understanding fibrosis in systemic sclerosis., shifting paradigms, emerging opportunities [J]. Nat Rev Rheumato1,2012,8(1) :42 - 54.
  • 9Varga J,Pasche B. Transforming growth factor beta as a therapeutic target in systemic sclerosis [ J]. Nat Rev Rheumatol, 2009,5 (4) : 200 - 206.
  • 10Ihn H. Scleroderma, fibroblasts, signaling, and excessive extracellular matrix[J]. Curt Rheumatol Rep, 2005,7 (2) : 156 - 162.

共引文献11

同被引文献19

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部